Lomé, August 12, 2026 — The West African pharmaceutical landscape is at a critical juncture. Massive drug imports or the development of a robust local health industry: the region faces a decisive choice. This pivotal moment brought together medical and academic leaders at the Agora Senghor in Lomé, laying the groundwork for a radical overhaul of West Africa’s health strategy.
During the 21st edition of the Federation of West African Pharmacy Students (FESPAO) Scientific and Cultural Conference, a new generation of medical professionals is no longer merely requesting increased funding—they are demanding a fundamental shift in approach. The outdated model of pharmacies as mere distribution points is being abandoned in favor of industrialization, genomic research, and the scientific validation of traditional knowledge.
ADVERTISEMENT
Local production: a national security imperative
The global pandemic and recent supply chain disruptions have exposed a harsh reality: reliance on imported pharmaceuticals is no longer just an economic burden—it represents a critical national security vulnerability. This was the central argument driving discussions at the summit.
Professor Gado Tchangbédji, Togo’s Minister Delegate for Higher Education and Research, outlined the government’s new direction under President Faure Essozimna Gnassingbé: transforming local pharmaceutical innovation and production into the region’s first line of defense against future health crises. To achieve this, the state is pledging substantial support for scientific cooperation and applied research initiatives.
Genomic epidemiology and indigenous knowledge take center stage
Yet simply producing medications locally falls short if the approach merely replicates foreign patents. True sovereignty demands therapies tailored to Africa’s unique health landscape. By prioritizing genomic epidemiology, the Lomé conference highlights an urgent scientific priority: developing treatments aligned with African genetic profiles, which have been consistently underrepresented in global clinical trials.
Complementing this cutting-edge science is a bold cultural reassertion. Experts advocate for the industrial-scale validation of traditional medicine. No longer content with informal herbal remedies, they propose subjecting centuries-old pharmacopeia to rigorous clinical testing to uncover and patent entirely new African-derived active compounds.
Redefining the pharmacist’s role
This industrial and scientific transformation faces a significant human capital challenge. As the sector evolves, so must academic training. Professor Tchin Darré, Togo’s Minister Delegate for Health and Dean of the Faculty of Health Sciences at the University of Lomé, identified the cornerstone of this revolution: curriculum reform. West Africa’s future pharmacists must transcend their current role as mere dispensers behind a counter. Their training must equip them as cutting-edge researchers, key players in manufacturing, and specialists in validating indigenous medical knowledge.
As deliberations continue in Lomé, the 21st FESPAO conference aims to translate these academic discussions into enforceable public policy proposals. The goal is clear: ensure that universal healthcare access in West Africa no longer depends on factories located thousands of miles from its patients.
The stakes could not be higher. Without a strong local pharmaceutical industry and research ecosystem rooted in African realities, West Africa will remain beholden to external solutions. In the face of future pandemics, this dependence could have devastating consequences. True health sovereignty will be measured by each nation’s ability to turn these resolutions into tangible action—ensuring every patient has access to treatments conceived, validated, and manufactured on African soil.
